Share this @internewscast.com

Key Points
  • US FDA has approved Gilead’s twice-yearly HIV prevention jab, branded as Yeztugo.
  • Lenacapavir injection proved nearly 100 per cent effective in large-scale clinical trials.
  • Gilead is planning a rapid launch in the US as well as a wider rollout of the drug in collaboration with global partners.
The US Food and Drug Administration has approved Gilead Sciences’ lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents.
Investors and AIDS activists had been eagerly awaiting the regulatory decision for the drug with the potential to help end the 44-year-old HIV epidemic.
The drug will be sold under the brand name Yeztugo in the US at a list price of $43,300 (US$28,218) a year.

Lenacapavir, belonging to a group of drugs called capsid inhibitors, demonstrated almost 100 percent effectiveness in preventing HIV during significant trials last year. This success has sparked new optimism about stopping the transmission of a virus that affects 1.3 million individuals annually.

Yeztugo “will only be as effective as it is accessible and affordable,” Kevin Robert Frost, CEO of the Foundation for AIDS Research, said in a statement, calling on Gilead and the US government to make sure people who want lenacapavir can get it.
Gilead said it will provide co-pay assistance for eligible insured people and that the drug may be made available free of charge under its program for the uninsured.
Medications to prevent HIV, known as pre-exposure prophylaxis or PrEP, are widely available. But most are daily pills, including low-cost generic versions of Gilead’s older drug Truvada, that require strict adherence to be effective.

Gilead said Yeztugo is priced in line with other branded drugs.

“This is a milestone moment,” said Gilead chief executive Daniel O’Day of the approval.

“We believe that lenacapavir is the most significant tool we have so far to change the course of the epidemic and eventually consign it to history,” O’Day stated.

Gilead has plans for a rapid launch in the United States as well as a wider rollout of the drug in collaboration with global partners.
Gilead chief commercial officer Johanna Mercier said the company’s “end game” is to normalise PrEP usage, both in the United States and other countries, including low-income African nations where the virus is most prevalent.

Share this @internewscast.com
You May Also Like
Bee attack leaves 24 people injured in French town of Aurillac

Bee Swarm Injures 24 in Aurillac, France

An unexpected bee attack in the French town of Aurillac resulted in…
Trump announces 25 per cent tariff on two key trading partners

Trump imposes a 25% tariff on two major trade allies

US President Donald Trump has intensified the pressure on two significant American…

Over 80 Dead in Texas Flash Floods, Including Campers; Dozens Still Missing

Key Points Over 80 people are confirmed dead after flash floods swept…
Tradie in court after alleged renovation scam costs families thousands

Construction Worker Faces Court Over Alleged Renovation Scam Affecting Families

A warning has been issued after almost a dozen Perth families allegedly…
Sonny Bill Williams (left) meets Mail Sport's Nik Simon at Opetaia Boxing Club in Sydney

Getting Punched by Sonny Bill Williams: What Happened Next and His Thoughts on the Lions

For a few seconds, I am flat on the floor of the…

Trump Announces 25% Tariffs on Japan and South Korea in Initial Phase

Key Highlights Donald Trump has introduced tariffs targeting Japan, South Korea, South…
Authorities say the spread shouldn't impact the nearby dolphin sanctuary, as the state government announces fee relief for affected fishers.

Harmful Algae Bloom Threatens Dolphin Sanctuary Nearby

The algal bloom devastating South Australian marine life has now been found…

An $82 Million Australian Industry Boom Leaves Some Behind

For Brisbane-based chef Chris Jordan, food has always been a language —…
CCTV footage of Burwood salon fire

Man Flees in Flames from Mysterious Fire at Sydney Salon

Police have released CCTV footage following a “suspicious” fire at a salon…
Vials of the Pfizer/BioNTech Comirnaty vaccine.

Dismissed Queensland Teachers Allowed to Appeal COVID Vaccine Termination

Teachers sacked for refusing to get the COVID-19 vaccine and small business…

Tour de France: Merlier Triumphs in Chaotic Third Stage as Philipsen Withdraws Due to Injuries

Belgian cyclist Tim Merlier pipped Italian Jonathan Milan right at the line…
French gameshow contestant's epic 21-month winning streak finally ends

French Game Show Contestant’s Remarkable 21-Month Winning Streak Comes to an End

A French game show participant has been dethroned following a record-setting streak…